Job description:
The position is located in the Section of Radiobiology & Tumor Immunotherapy of the Department of Radiation Oncology, University Medical Center Freiburg. We study combinations of immunotherapeutics with focal radiation therapy (RT). This includes the combination of RT with active immunotherapeutics as well as cellular immunotherapeutics such as CAR T cells. Our research involves both the use of mouse tumor models and immunophenotyping of patient samples.
The aim is to identify and develop effective combination therapies for the treatment of advanced / metastatic disease (see: Nat Commun. 2023, 14: 2087 PMID: 37045833; Clin Cancer Res 2023, 29: 667-683; Cancer Lett. 2022, 538: 215697; Cancer Immunol Immunother 2020, 69: 1823-1832; Clin Cancer Res 2020, 26: 945–956; Clin Cancer Res 2019, 25: 7243–7255; Nat Rev Dis Primers 2019, 5; Int J Radiat Oncol Biol Phys 2018, 101: 63–73).
Within the PhD project, you will combine research on mouse tumor models and characterization of patient samples.
In this position you have the opportunity to work in a laboratory that employs a variety of modern research methods in cell and molecular biology, tumor immunology and tumor immunotherapy.
For more information, please visit: https://www.uniklinik-freiburg.de/strahlenklinik/sektion-strahlenbiologie.html or https://www.uniklinik-freiburg.de/strahlenklinik-en/section-of-radiobiology.html